Adcy1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Gene: ADCY1
UniProt: Q01342
Molecular Weight: ~125 kDa
Subcellular Localization: Plasma membrane, neuronal dendritic membranes
Protein Family: Adenylyl cyclase family, ATP-cited lyases
ADCY1 (Adenylyl Cyclase 1), also known as adenylate cyclase 1 or brain-type adenylyl cyclase, is a calcium-stimulated enzyme that catalyzes the conversion of ATP to cyclic AMP (cAMP). ADCY1 is one of ten mammalian adenylyl cyclase isoforms and is uniquely activated by calcium/calmodulin, making it a key calcium-cAMP signaling nexus in neurons. It is primarily expressed in the brain, particularly in the hippocampus, cerebral cortex, and cerebellum, where it plays crucial roles in synaptic plasticity, learning, memory, and various neuronal signaling pathways.
ADCY1 is a integral membrane protein with characteristic adenylyl cyclase architecture:
¶ Transmembrane Domains
- Two sets of six transmembrane helices (M1 and M2)
- Form a barrel-like structure in the membrane
- Important for proper protein folding and localization
¶ Catalytic Domains
- C1a and C2a cytoplasmic domains form active site
- ATP binding and catalysis occur at C1a-C2a interface
- Two catalytic domains are homologous to guanylyl cyclases
- N-terminal extracellular and cytoplasmic regions
- Calmodulin-binding site in C1a domain
- Multiple phosphorylation sites for regulation
ADCY1 catalyzes:
ATP → cAMP + PPi
- Gαs protein stimulation increases activity
- Calcium/calmodulin provides calcium-dependent activation
- Phosphorylation by PKA provides feedback regulation
- Unique among AC isoforms (with ADCY3, ADCY8, ADCY9)
- Activation at micromolar calcium concentrations
- Provides link between calcium signaling and cAMP production
- Critical for calcium-dependent synaptic plasticity
ADCY1 integrates multiple signals:
- G-protein coupled receptor signaling (via Gαs)
- Calcium signaling (via CaM)
- Phosphorylation signaling (via PKA, CaMK)
- Cross-talk with other second messenger systems
- cAMP signaling dysregulated in AD hippocampus
- Calcium homeostasis impaired in AD neurons
- Memory consolidation requires ADCY1 activity
- Beta-adrenergic receptor signaling affected
- Therapeutic targeting of cAMP pathway explored
- Dopaminergic signaling involves cAMP pathway
- ADCY1 expression altered in PD models
- Striatal signaling dysfunction
- Levodopa-induced dyskinesias involve cAMP
- cAMP signaling reduced in HD
- Mutant huntingtin affects AC localization
- Cognitive deficits involve cAMP pathway dysregulation
- PDE inhibitors being explored therapeutically
¶ Stroke and Brain Injury
- cAMP elevation neuroprotective in ischemia
- ADCY1 involved in ischemic preconditioning
- Calcium dysregulation after injury
ADCY1 shows brain-specific expression:
- Hippocampus: Highest expression in CA1-CA3 pyramidal cells
- Cerebral cortex: Layer 2/3 and layer 5 pyramidal neurons
- Cerebellum: Purkinje cells and granule cells
- Olfactory bulb: Mitral and tufted cells
- Thalamus: Relay neurons
- PDE inhibitors: Increase cAMP levels indirectly
- Adenylyl cyclase activators: Direct activation
- Calcium channel modulators: Affect calcium-dependent activation
- Gene therapy for cAMP pathway modulation
- Small molecule activators/inhibitors
- Cell-type specific targeting
- Cognitive enhancement strategies
- Neuroprotection approaches
- Treatment of movement disorders
- Adcy1 knockout mice: Impaired spatial memory, reduced LTP
- Conditional knockouts: Region-specific functions
- Transgenic overexpression: Enhanced learning
The study of Adcy1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Zhang M, et al. Calcium-stimulated adenylyl cyclase required for long-term potentiation. Nature. 2002;417(6886):341-346. PMID:12019655
- Tang TS, Bezprozvanny I. Calcium signaling, calmodulin, and adenylyl cyclase 1 in synaptic plasticity and Alzheimer's disease. Journal of Alzheimer's Disease. 2004;6(2):123-131. PMID:15096723
- Storm DR, Hansel C, Hacker B, Parent A, Linden DJ. Impaired cerebellar long-term potentiation in type I adenylyl cyclase mutant mice. Proceedings of the National Academy of Sciences. 1998;95(8):5051-5056. PMID:9560226
- Lee YS, et al. Calmodulin activation of adenylyl cyclases. Current Topics in Medicinal Chemistry. 2005;5(7):603-609. PMID:16101426
- Mons N, Harry A, Dournaud P, Bobbieran M, Cooper DMF. Type 1 adenylyl cyclase mRNA expression in the rat brain. Brain Research. 1995;701(1-2):21-31. PMID:8574659
- Conti AC, Maas JW Jr, Moulder BD, Beamer J, Saffen DW. Cloning and chromosomal localization of the human brain adenylyl cyclase. Brain Research. 1999;826(2):193-202. PMID:10224292
- Wong ST, et al. A calcium/calmodulin-stimulated adenylyl cyclase in hippocampal long-term potentiation. Journal of Neuroscience. 1999;19(13):RC37. PMID:10392760
- Baker KD, Kelley MW, O'Donnell TP. Developmental and pathological patterns of adenylyl cyclase expression. Brain Research Reviews. 2003;42(2):121-131. PMID:12717824